Mar 15, 2022

Sigyn Therapeutics Names Leading Nephrologist Dr. H. David Humes to SAB

Mar 9, 2022

Sigyn Appoints Internationally Recognized Nephrologist Dr. Alexander Yevzlin to SAB

Feb 25, 2022

BioTech IQ:Treatments that can reach beyond on the function of drugs? James Joyce, CEO - Sigyn Therapeutics

Feb 23, 2022

Biotech Tuesdays: Sigyn Therapeutics completes animal studies; Sigyn Therapy safe and well tolerated

Feb 15, 2022

Sigyn Therapeutics hopes to file IDE in Q2 for human studies of Sigyn Therapy

Feb 14, 2022

Finding Genius Podcast: Therapeutic Blood Purification and Its Potential to Treat Life-Threatening Conditions with Jim Joyce

Jan 20, 2022

How COVID-19 Has Spurred A Shift to Broad-Spectrum Countermeasures Against Viruses

Jan 19, 2022

Sigyn Therapeutics featured in BioSpace, twice

Jan 17, 2022

A Perfect Storm of Superbugs

Jan 11, 2022

Sigyn Therapeutics: Calming and Preventing the Cytokine Storm